Quantum Solutions Synergiques Inc. • 819-643-1420 • Gatineau QC Canada
Quantum Synergy Solutions: A Micro-Algae Research Laboratory
ABOUT US
OUR MISSION: To develop and produce bioactive molecules derived from micro-algae for the functional food, supplement, cosmetic and pharmaceutical products markets.
QUANTUM SYNERGY SOLUTIONS
OUR TECHNOLOGY
BOARD OF DIRECTORS
OUR TECHNOLOGY
Our modular photobioreactor system allows the controlled growth of micro-algae in a fully sanitary and controlled environment from the beginning to the end of the process.
THE TEAM
BOARD OF DIRECTORS
OUR TECHNOLOGY
Our research team has solid experience in cell and molecular biology, engineering, project management, quality systems, regulatory affairs and clinical studies.
BOARD OF DIRECTORS
BOARD OF DIRECTORS
BOARD OF DIRECTORS
Professionals involved and concerned about the quality of health products.
OUR TECHNOLOGY
The result of an extensive research process
Our modular photobioreactor system allows controlled growth of micro-algae in a fully sanitary and controlled environment from start to finish. Accumulation of astaxanthin inside Haematococcus pluvialis cells requires a two-step process with very different environmental parameters. The majority of producers therefore carry out cell growth indoors followed by the maturation phase outdoors in artificial open ponds. This method increases the risk of contamination by bacteria, parasites or other unwanted algae.
We have designed our photobioreactors in order to not only optimize the cell growth cycle of our algae but also to carry out the maturation phase. By optimizing the two phases inside the same bioreactor, we can maximize the accumulation of astaxanthin in the cells while significantly reducing the risks of contamination and therefore improving the quality of the product, without antibiotic agents.
For optimal cell growth, high purity water is necessary. In addition, we only use food-grade vitamins and nutrients to feed our algae and we plan a complete analysis of the life cycle of the process, including the recycling of water, in order to minimize our ecological footprint.
Once our algae are harvested, the process of extracting astaxanthin can begin. Cell lysis is typically done by chemical or enzymatic degradation of the cell wall, which can leave traces of dangerous chemicals in the extracts. Our process uses only high pressure mechanical methods in order to achieve complete and effective lysis without the use of chemicals.
The drying step is then carried out by lyophilization (freeze-drying), a method ensuring optimal conservation of the nutritional characteristics of the algae.
The final stage is carried out by supercritical CO2 extraction at very high pressures. This allows us to obtain an oily extract rich in bioactive compounds such as Omega-3, Omega-6 as well as astaxanthin and other carotenoids. Again, this method uses no chemicals harmful to health unlike conventional extractions. In addition, the CO2 is fully recycled after use.
Our scientific research program combined with the use of new efficient and safe technologies for health and the environment ensures we obtain a final product of superior quality.
THE TEAM
The Quantum Synergy Solutions team is made up of engineers and scientists with decades of experience in the highly regulated biotechnology markets.
In recent years we have developed a unique photobioreactor technology and have carried out advanced research projects in the fields of extraction processes, in partnership with recognized research centers.
Our goal is to provide high quality micro-algae, extracts and bioactive molecules for today's and tomorrow's nutritional, supplement and cosmetic markets.
BOARD OF DIRECTORS
Patrick Chauvet, M.Sc., Cofounder & CEO
Mr. Chauvet has close to 20 years of experience in cell biology, pre-clinical and clinical research including protocol development, trial management, data analysis and regulatory submissions for high tech medical device companies. Mr. Chauvet holds a Masters degree in cellular and molecular biology and has authored numerous scientific publications. Mr. Chauvet has held senior management positions at CryoCath Technologies Inc. and consulted for several established and startup biotech firms including Medtronic, Farapulse, Jubilant Draximage, AgileMV and SigNum.
Jean-Luc Pageard, Ing., Cofounder
Mr. Pageard has close to 20 years of management experience in research and development, quality assurance, business development and marketing for high tech medical device companies. Mr. Pageard has started and managed numerous successful businesses over the last 30 years and is Co-founder & President of AgileMV, a Medical Device company based in Montreal. He has authored 20+ patents in the biomedical field.
Steve Gannon, CA, CPA, EMBA, Independent Board Member
Mr. Gannon has close to 30 years of biotech, pharma and medical device experience. His specific areas of expertise include international business development, mergers and acquisitions, business startups and initial public offerings. He has held Chief Financial Officer positions at Mallinckrodt, CryoCath and Aptalis Pharma and was Director of Finance at AstraZeneca. He sits on the board of several international biotech and pharmaceutical companies.
Pierre Ménard, Director
Mr. Ménard is a businessman with almost 40 years of experience in various retail, construction and catering businesses. He is Co-founder and CEO of La Boite à Grains, a chain of stores for natural and organic health products. Mr. Ménard has twice won the Excelor Prize from the Gatineau Chamber of Commerce (CCG) as well as of the Order of Merit of the Quebec Chamber of Commerce and Industry (CCIQ). Mr. Ménard also sits on various corporate boards in the region, including as Vice-President of the Board of Directors of Caisse Populaire Desjardins St-Joseph. He is a member of the Canadian Health Food Association (ACAS), the Health First Network (HFN) and a member and laureate of the Mentoring Unit of the Gatineau Chamber of Commerce.
Jean-Marc Gerfaux, Director
Jean-Marc Gerfaux is a graduate engineer from the École de Technologie Supérieure in Montreal and holds a diploma in Higher Technology from the University of Grenoble in France in the field of construction. With a 25-year career, Mr. Gerfaux has participated in numerous major commercial and industrial building projects in the Outaouais region. He also participated in major civil engineering projects in France such as tunnels and other industrial works. Mr. Gerfaux is today one of the main shareholders of Boless, an active player in the field of commercial construction in the National Capital Region.